Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

BACKGROUND: Patients with dilated cardiomyopathy whose symptoms and cardiac function have recovered often ask whether their medications can be stopped. The safety of withdrawing treatment in this situation is unknown. METHODS: We did an open-label, pilot, randomised trial to examine the effect of ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Halliday, Brian P, Wassall, Rebecca, Lota, Amrit S, Khalique, Zohya, Gregson, John, Newsome, Simon, Jackson, Robert, Rahneva, Tsveta, Wage, Rick, Smith, Gillian, Venneri, Lucia, Tayal, Upasana, Auger, Dominique, Midwinter, William, Whiffin, Nicola, Rajani, Ronak, Dungu, Jason N, Pantazis, Antonis, Cook, Stuart A, Ware, James S, Baksi, A John, Pennell, Dudley J, Rosen, Stuart D, Cowie, Martin R, Cleland, John G F, Prasad, Sanjay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319251/
https://www.ncbi.nlm.nih.gov/pubmed/30429050
http://dx.doi.org/10.1016/S0140-6736(18)32484-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319251/
https://www.ncbi.nlm.nih.gov/pubmed/30429050
http://dx.doi.org/10.1016/S0140-6736(18)32484-X

Ejemplares similares